Chubachi Shotaro, Sato Minako, Kameyama Naofumi, Tsutsumi Akihiro, Sasaki Mamoru, Tateno Hiroki, Nakamura Hidetoshi, Asano Koichiro, Betsuyaku Tomoko
Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Japan.
Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Japan.
Respir Med. 2016 Aug;117:272-9. doi: 10.1016/j.rmed.2016.07.002. Epub 2016 Jul 7.
Patients with chronic obstructive pulmonary disease (COPD) frequently suffer from various comorbidities. Recently, cluster analysis has been proposed to examine the phenotypic heterogeneity in COPD. In order to comprehensively understand the comorbidities of COPD in Japan, we conducted multicenter, longitudinal cohort study, called the Keio COPD Comorbidity Research (K-CCR). In this cohort, comorbid diagnoses were established by both objective examination and review of clinical records, in addition to self-report. We aimed to investigate the clustering of nineteen clinically relevant comorbidities and the meaningful outcomes of the clusters over a two-year follow-up period.
The present study analyzed data from COPD patients whose data of comorbidities were completed (n = 311). Cluster analysis was performed using Ward's minimum-variance method.
Five comorbidity clusters were identified: less comorbidity; malignancy; metabolic and cardiovascular; gastroesophageal reflux disease (GERD) and psychological; and underweight and anemic. FEV1 did not differ among the clusters. GERD and psychological cluster had worse COPD assessment test (CAT) and Saint George's respiratory questionnaire (SGRQ) at baseline compared to the other clusters (CAT: p = 0.0003 and SGRQ: p = 0.00046). The rate of change in these scores did not differ within 2 years. The underweight and anemic cluster included subjects with lower baseline ratio of predicted diffusing capacity (DLco/VA) compared to the malignancy cluster (p = 0.036).
Five clusters of comorbidities were identified in Japanese COPD patients. The clinical characteristics and health-related quality of life were different among these clusters during a follow-up of two years.
慢性阻塞性肺疾病(COPD)患者常伴有多种合并症。最近,有人提出用聚类分析来研究COPD的表型异质性。为了全面了解日本COPD患者的合并症情况,我们开展了一项多中心纵向队列研究,即庆应义塾大学慢性阻塞性肺疾病合并症研究(K-CCR)。在这个队列中,除了自我报告外,还通过客观检查和临床记录回顾来确定合并症诊断。我们旨在调查19种临床相关合并症的聚类情况以及这些聚类在两年随访期内的有意义结局。
本研究分析了合并症数据完整的COPD患者的数据(n = 311)。使用Ward最小方差法进行聚类分析。
识别出五个合并症聚类:合并症较少;恶性肿瘤;代谢和心血管疾病;胃食管反流病(GERD)和心理问题;体重过轻和贫血。各聚类间第一秒用力呼气容积(FEV1)无差异。与其他聚类相比,GERD和心理问题聚类在基线时的慢性阻塞性肺疾病评估测试(CAT)和圣乔治呼吸问卷(SGRQ)得分更差(CAT:p = 0.0003,SGRQ:p = 0.00046)。这些得分在2年内的变化率无差异。与恶性肿瘤聚类相比,体重过轻和贫血聚类中的受试者基线预测弥散能力(DLco/VA)比值较低(p = 0.036)。
在日本COPD患者中识别出五个合并症聚类。在两年的随访期间,这些聚类的临床特征和健康相关生活质量有所不同。